GMT Genomtec S.A.

0.6215USD2.500 PLN · GPW-3.85%Mkt Cap: 10.61M USDP/E: —

Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that enables t…

Key Statistics

Company
Market Cap10.61M USD
Enterprise Value7.47M USD
Revenue (TTM)8.70K USD
Gross Profit-1.98M USD
Net Income (TTM)-2.59M USD
Revenue/Share0.0005 USD
Last Price0.6215 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLGNMTC00017
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-6.07
EV/Revenue859.02
P/S1218.90
P/B2.72
EPS (TTM)-0.12 USD
EPS (Forward)—
52W Range
0.58423% of range1.708
52W High1.708 USD
52W Low0.5842 USD
Profitability
Gross Margin-37909.52%
Oper. Margin-20917.14%
EBITDA Margin0.00%
Profit Margin-49671.43%
ROE-113.21%
ROA-67.92%
ROIC-158.80%
ROCE-90.59%
Growth
Revenue Growth83.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.78M USD
CapEx (TTM)22.87K USD
FCF Margin-4702.50%
FCF Yield-3.86%
Net Debt-3.13M USD
Net Debt/EBITDA2.54
Net Debt/FCF—
Balance Sheet
Debt/Equity0.21
Current Ratio4.05
Quick Ratio3.78
Book Value/Sh0.23 USD
Cash/Share0.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.17.06M
Float11.77M
Insiders15.37%
Institutions2.93%
Technical
SMA 500.7508 (-17.2%)
SMA 2001.061 (-41.4%)
Beta0.43
S&P 52W Chg12.00%
Avg Vol (30d)36.69K
Avg Vol (10d)35.71K
Technical Indicators
RSI (14)38.6
MACD-0.1177
MACD Signal-0.1448
MACD Hist.+0.0271
BB Upper0.7079 USD
BB Middle0.6504 USD
BB Lower0.5928 USD
BB Width17.70%
ATR (14)0.0425 USD
Vol Ratio (20d)0.47x

About Genomtec (WSE: GMT)

›

Genomtec (WSE: GMT) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 32 employees.

The shares were at 2.500 PLN on 19 November 2026, down 46.2% over 52 weeks. Its 52-week range is 2.350 PLN to 6.870 PLN: the price is 63.6% below the high and 6.4% above the low.

Its market capitalisation is 42.66M PLN.

Genomtec reports return on equity of -113.2% and revenue up 83.3% year over year.

It holds more cash than debt, a net cash position of 12.60M PLN. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.